(Q38162367)

30 August 2017

title

C-reactive protein and hypertension (English)

1 reference

30 August 2017

main subject

arterial hypertension

0 references

author

Fadi G. Hage

series ordinal

1

1 reference

30 August 2017

publication date

14 November 2013

1 reference

Journal of Human Hypertension

30 August 2017

published in

1 reference

30 August 2017

volume

28

1 reference

30 August 2017

issue

7

1 reference

30 August 2017

page(s)

410-415

1 reference

Inflammation, immunity, and hypertension

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Essential hypertension: is there a role for inflammatory mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Biomarkers of inflammation and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Cardiovascular risk factors in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein in ischemic stroke: an independent prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive Protein among Community-Dwelling Hypertensives on Single-agent Antihypertensive Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein and the risk of developing hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Multiple biomarkers and the risk of incident hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein implications in new-onset hypertension in a healthy population initially aged 65 years: the Proof study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein predicts systolic blood pressure and pulse pressure but not diastolic blood pressure: the Cardiovascular Disease Risk Factors Two-Township Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Changes in the concentration and composition of plasma lipoproteins during the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Association of C-Reactive Protein With Blood Pressure and Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Association study of CRP gene polymorphism and hypertension in Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein-mediated vascular injury requires complement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.111

Hypertension and C-reactive protein

21 January 2018

1 reference

12 December 2020

C-reactive protein makes human endothelium stiff and tight

1 reference

12 December 2020

C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction

1 reference

12 December 2020

Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial

1 reference

12 December 2020

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

12 December 2020

C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice

1 reference

12 December 2020

Cardiovascular disease. Massive trials to test inflammation hypothesis

1 reference

12 December 2020

Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein

1 reference

12 December 2020

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

1 reference

12 December 2020

C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction

1 reference

12 December 2020

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease

1 reference

12 December 2020

C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident essential hypertension: findings from an observational cohort of Han Chinese

1 reference

12 December 2020

Identifiers

DOI

10.1038/JHH.2013.111

1 reference

Dimensions Publication ID

30 August 2017

1043256016

0 references

1 reference